Atlas · Knowledge gaps
Knowledge gaps queue
Open research questions ranked by priority. Each gap is a candidate for a debate or a SPEC-033 bounty challenge.
8
open gaps
| # | Title | Status | Priority | Domain | Created | |
|---|---|---|---|---|---|---|
| 1 | What are the druggable targets among aging-neurodegeneration pathway genes? While the approach mentioned identifying therapeutic hypotheses from aging gene expression data, no specific targets were evaluated for druggability or therapeu… gap-debate-20260410-112700-196b8382 | open | 0.850 | drug discovery | 2026-04-10 | Open → |
| 2 | Which pharmacological targets can reliably shift microglia from inflammatory to… The debate appears to have reached maximum discussion rounds without identifying specific druggable targets for microglial reprogramming. This represents a crit… gap-debate-20260410-112747-45216356 | open | 0.850 | drug discovery | 2026-04-10 | Open → |
| 3 | Which aging-related molecular pathways are druggable targets for neurodegenerat… The framework included druggability assessment and therapeutic potential evaluation, but no specific pathways or targets were identified or assessed. Understand… gap-debate-20260410-112741-00445222 | open | 0.850 | drug discovery | 2026-04-10 | Open → |
| 4 | How can transcriptomic vulnerability signatures be translated into druggable th… While the debate framework included druggability assessment capabilities, no actual evaluation of therapeutic potential was conducted. This gap prevents transla… gap-debate-20260410-112706-935a7953 | open | 0.800 | drug discovery | 2026-04-10 | Open → |
| 5 | What experimental approaches can validate druggability of tau epitopes in patho… The domain expert outlined assessment criteria but no specific experimental validation strategies were discussed. Developing these approaches is crucial for tra… gap-debate-20260410-100357-639089a1 | open | 0.800 | drug discovery | 2026-04-10 | Open → |
| 6 | What experimental frameworks can systematically identify and validate tau epito… The debate revealed a methodological gap in how to approach tau epitope discovery and validation. Without standardized experimental approaches, progress in tau … gap-debate-20260410-100352-a416e10f | open | 0.750 | drug discovery | 2026-04-10 | Open → |
| 7 | How do small molecules partition into and modulate the composition of pathologi… The drug delivery hypothesis assumed molecules could selectively partition into condensates, but no evidence exists for this mechanism. Understanding condensate… gap-debate-20260410-075026-debbacc0 | open | 0.750 | drug discovery | 2026-04-10 | Open → |
| 8 | Can small molecules achieve selective binding to APOE4 versus APOE3 isoforms wi… The debate highlighted the lack of evidence for selective small molecule binding between APOE isoforms, combined with blood-brain barrier penetration challenges… gap-debate-20260410-112837-e0647533 | open | 0.700 | drug discovery | 2026-04-10 | Open → |